Table 1.
Gender | Age (yr) | HSV antibody(ies)a | Time (yr) since first meningitis | No. of recurrences |
Time since last meningitis | |
---|---|---|---|---|---|---|
Laboratory diagnosed | Clinically suspected | |||||
Female | 49 | HSV-2 | 6 | 4 | 0 | 6 mo |
Female | 29 | HSV-2 | 5 | 3 | 3 | 6 mo |
Female | 41 | HSV-2 | 4 | 3 | 4 | 8 mo |
Female | 29 | HSV-2 | 3 | 5 | 15 | 3 mo |
Female | 51 | HSV-2 | 33 | 7 | 1 | 1 mo |
Female | 39 | HSV-2 | 10 | 4 | 6 | 5 mo |
Female | 62 | HSV-2 | 33 | 5 | 20 | 6 mo |
Male | 38 | HSV-2 | 15 | 6 | 58 | 2 wk |
Female | 49 | HSV-2 | 26 | 5 | 2 | 4 mo |
Female | 51 | HSV-1, -2 | 13 | 7 | 18 | 10 mo |
The presence of HSV-1 or -2 was confirmed by PCR or culture of cerebrospinal fluid in the first three to seven episodes of each patient, as indicated. All patients included were asymptomatic at the time of inclusion.